trial · primary record
Laboratory Biomarker Analysis
Anaplastic Large Cell Lymphoma
| Phase | Phase 2 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 12 |
| Primary completion | 2023-07-26 |
| Primary endpoint | Number of Patients With Grade 3 or Above Toxicities |
| Registry ID | NCT03534180 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:33:03.488Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT03534180
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Laboratory Biomarker Analysis · compound